16th Jan 2007 07:01
Skyepharma PLC16 January 2007 FOR IMMEDIATE RELEASE 16 JANUARY 2007 SkyePharma PLC CIRCULAR POSTED TODAY TO SHAREHOLDERS London, England, 16 January, 2007 - SkyePharma PLC (LSE: SKP; NASDAQ: SKYE)announces that, further to its announcement on 9 January 2007, a Circular, whichdetails the proposed disposal of its Injectable Business and the proposedplacing with certain institutional investors, will today be posted toshareholders of the Company. The Circular includes a notice convening an Extraordinary General Meeting to beheld on 8 February 2007 at 10am at Stringer Saul LLP, First Floor, 17 HanoverSquare, London W1S 1HU at which resolutions will be proposed, inter alia, toapprove the disposal and the issue of shares under the placing. The Circular will shortly be available for inspection at the UK ListingAuthority's Document Viewing Facility at the Financial Services Authority, 25The North Colonnade, Canary Wharf, London E14 5HS. EXPECTED TIMETABLE OF KEY EVENTS Posting of Circular to Shareholders 16 January 2007 Latest time and date for receipt of Forms of Proxy 10am on 6 February 2007 Extraordinary General Meeting 10 am on 8 February 2007 Expected date of completion of the Disposal 9 February 2007 Expected date of Placing Shares being admitted 12 February 2007 For further information please contact: SkyePharma PLC +44 207 491 1777Frank Condella, Chief Executive OfficerKen Cunningham, Chief Operating OfficerPeter Grant, Finance Director Buchanan Communications +44 207 466 5000Tim Anderson / Mark Court / Rebecca Skye Dietrich Trout Group (US)Seth Lewis +(1) 617-583-1308 Notes for editors About SkyePharma SkyePharma PLC develops pharmaceutical products benefiting from world-leadingdrug delivery technologies that provide easier-to-use and more effective drugformulations. There are now eleven approved products incorporating SkyePharma'stechnologies in the areas of oral, injectable, inhaled and topical delivery,supported by advanced solubilisation capabilities. For more information, visitwww.skyepharma.com. These materials are not an offer for sale of securities in the United States.The securities in the placing have not been and will not be registered under theUS Securities Act of 1933 (the "Securities Act") and the securities may not besold in the United States absent registration or an exemption from registrationunder the Securities Act. The Company does not intend to register any portion ofsuch offering in the United States or to conduct a public offering of theordinary shares in the United States. The information contained herein does not constitute an offer to sell or thesolicitation of an offer to buy nor shall there be any sale of the securitiesreferred to herein in any jurisdiction in which such offer, solicitation or salewould be unlawful prior to registration, exemption from registration orqualification under the securities laws of any jurisdiction. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
SKP.L